ClinicalTrials.Veeva

Menu

Observational Study of the Long-term Effect of Latanoprost in Normal Tension Glaucoma (NTG-X-PERT)

Viatris logo

Viatris

Status

Completed

Conditions

Low Tension Glaucoma

Study type

Observational

Funder types

Industry

Identifiers

NCT01209624
A6111135

Details and patient eligibility

About

The purpose of this study is to assess the long-term efficacy and safety of latanoprost monotherapy in patients with normal tension glaucoma (NTG) using a prospective, observational design. Visits were scheduled at 6-month intervals for 24 months. Intraocular pressure (IOP), optic nerve head findings, visual field status, and adverse events were recorded.

Enrollment

902 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

patients with normal-tension glaucoma

Exclusion criteria

none

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems